| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Regulation of tumor angiogenesis by EZH2.
|
Cancer Cell
|
2010
|
3.10
|
|
2
|
Therapeutic Targeting of ATP7B in Ovarian Carcinoma.
|
Clin Cancer Res
|
2009
|
1.61
|
|
3
|
Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis.
|
J Biol Chem
|
2010
|
1.58
|
|
4
|
Single-port-access laparoscopic-assisted vaginal hysterectomy versus conventional laparoscopic-assisted vaginal hysterectomy: a comparison of perioperative outcomes.
|
Surg Endosc
|
2010
|
1.46
|
|
5
|
Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles.
|
Neoplasia
|
2011
|
1.42
|
|
6
|
Single port access laparoscopic adnexal surgery.
|
J Minim Invasive Gynecol
|
2009
|
1.40
|
|
7
|
Pretreatment neutrophil:lymphocyte ratio as a prognostic factor in cervical carcinoma.
|
Anticancer Res
|
2012
|
1.36
|
|
8
|
Single-port access laparoscopic-assisted vaginal hysterectomy: a novel method with a wound retractor and a glove.
|
J Minim Invasive Gynecol
|
2009
|
1.32
|
|
9
|
Dual targeting of EphA2 and FAK in ovarian carcinoma.
|
Cancer Biol Ther
|
2009
|
1.30
|
|
10
|
Benign metastasizing leiomyoma with multiple lymph node metastasis: a case report.
|
Cancer Res Treat
|
2011
|
1.29
|
|
11
|
Adenoid cystic carcinoma of the Bartholin's gland: report of two cases and review of the literature.
|
Gynecol Oncol
|
2005
|
1.25
|
|
12
|
Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level.
|
Gynecol Oncol
|
2011
|
1.22
|
|
13
|
Single port access laparoscopic adnexal surgery versus conventional laparoscopic adnexal surgery: a comparison of peri-operative outcomes.
|
Eur J Obstet Gynecol Reprod Biol
|
2010
|
1.19
|
|
14
|
Hypermethylation and loss of heterozygosity of tumor suppressor genes on chromosome 3p in cervical cancer.
|
Cancer Lett
|
2007
|
1.15
|
|
15
|
Prognosis of ovarian clear cell carcinoma compared to other histological subtypes: a meta-analysis.
|
Gynecol Oncol
|
2011
|
1.15
|
|
16
|
Splicing variant of AIMP2 as an effective target against chemoresistant ovarian cancer.
|
J Mol Cell Biol
|
2012
|
1.10
|
|
17
|
Functional roles of Src and Fgr in ovarian carcinoma.
|
Clin Cancer Res
|
2011
|
1.08
|
|
18
|
Determination of substrate specificity and putative substrates of Chk2 kinase.
|
Biochem Biophys Res Commun
|
2003
|
1.07
|
|
19
|
Single-port access subtotal hysterectomy with transcervical morcellation: a pilot study.
|
J Minim Invasive Gynecol
|
2009
|
1.07
|
|
20
|
The role of cytoreductive surgery for non-genital tract metastatic tumors to the ovaries.
|
Eur J Obstet Gynecol Reprod Biol
|
2009
|
1.06
|
|
21
|
The prognostic significance of the SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) of the cervical tumor in PET imaging for early cervical cancer: preliminary results.
|
Gynecol Oncol
|
2009
|
1.03
|
|
22
|
Papillary serous carcinoma in ovaries of normal size: a clinicopathologic study of 20 cases and comparison with extraovarian peritoneal papillary serous carcinoma.
|
Gynecol Oncol
|
2007
|
1.03
|
|
23
|
Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition.
|
J Gynecol Oncol
|
2013
|
1.02
|
|
24
|
Phase II study of consolidation chemotherapy after concurrent chemoradiation in cervical cancer: preliminary results.
|
Int J Radiat Oncol Biol Phys
|
2007
|
0.99
|
|
25
|
Tumor suppressive effects of bromodomain-containing protein 7 (BRD7) in epithelial ovarian carcinoma.
|
Clin Cancer Res
|
2013
|
0.97
|
|
26
|
High galectin-1 expression correlates with poor prognosis and is involved in epithelial ovarian cancer proliferation and invasion.
|
Eur J Cancer
|
2012
|
0.96
|
|
27
|
Bone metastasis in primary endometrial carcinoma: features, outcomes, and predictors.
|
Int J Gynecol Cancer
|
2014
|
0.96
|
|
28
|
A comparison of pure adenocarcinoma and squamous cell carcinoma of the cervix after radical hysterectomy in stage IB-IIA.
|
Gynecol Oncol
|
2010
|
0.96
|
|
29
|
Volumetric MR-guided high-intensity focused ultrasound ablation with a one-layer strategy to treat large uterine fibroids: initial clinical outcomes.
|
Radiology
|
2012
|
0.96
|
|
30
|
Synchronous gynecologic malignancy and preliminary results of Lynch syndrome.
|
J Gynecol Oncol
|
2011
|
0.95
|
|
31
|
The use of misoprostol before hysteroscopic surgery in non-pregnant premenopausal women: a randomized comparison of sublingual, oral and vaginal administrations.
|
Hum Reprod
|
2010
|
0.95
|
|
32
|
Prognostic value of the copper transporters, CTR1 and CTR2, in patients with ovarian carcinoma receiving platinum-based chemotherapy.
|
Gynecol Oncol
|
2011
|
0.95
|
|
33
|
Galectin 1 expression is associated with tumor invasion and metastasis in stage IB to IIA cervical cancer.
|
Hum Pathol
|
2012
|
0.94
|
|
34
|
Survival benefit from ovarian metastatectomy in colorectal cancer patients with ovarian metastasis: a retrospective analysis.
|
Cancer Chemother Pharmacol
|
2009
|
0.94
|
|
35
|
Comparison of outcomes between radical hysterectomy followed by tailored adjuvant therapy versus primary chemoradiation therapy in IB2 and IIA2 cervical cancer.
|
J Gynecol Oncol
|
2012
|
0.93
|
|
36
|
p53 alteration independently predicts poor outcomes in patients with endometrial cancer: a clinicopathologic study of 131 cases and literature review.
|
Gynecol Oncol
|
2009
|
0.93
|
|
37
|
Outcome and reproductive function after cumulative high-dose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumor.
|
Gynecol Oncol
|
2008
|
0.93
|
|
38
|
A matched-case comparison to explore the role of consolidation chemotherapy after concurrent chemoradiation in cervical cancer.
|
Int J Radiat Oncol Biol Phys
|
2010
|
0.91
|
|
39
|
Contributing factors for bone metastasis in uterine cervical cancer.
|
Int J Gynecol Cancer
|
2013
|
0.90
|
|
40
|
Gene expression profiling for the prediction of lymph node metastasis in patients with cervical cancer.
|
Cancer Sci
|
2007
|
0.90
|
|
41
|
Meta-analysis of the effects of beta blocker on survival time in cancer patients.
|
J Cancer Res Clin Oncol
|
2014
|
0.90
|
|
42
|
Laparoendoscopic single site (LESS) surgery in benign gynecology: perioperative and late complications of 515 cases.
|
Eur J Obstet Gynecol Reprod Biol
|
2013
|
0.89
|
|
43
|
Histologic distribution of borderline ovarian tumors worldwide: a systematic review.
|
J Gynecol Oncol
|
2013
|
0.89
|
|
44
|
Cost-effectiveness analysis of HLA-B5801 genotyping in the treatment of gout patients with chronic renal insufficiency in Korea.
|
Arthritis Care Res (Hoboken)
|
2015
|
0.88
|
|
45
|
Peritoneal tuberculosis: a retrospective review of 20 cases and comparison with primary peritoneal carcinoma.
|
Int J Gynecol Cancer
|
2010
|
0.87
|
|
46
|
Integrative analysis of copy number alteration and gene expression profiling in ovarian clear cell adenocarcinoma.
|
Cancer Genet
|
2013
|
0.87
|
|
47
|
Single port access laparoscopic-assisted vaginal hysterectomy for large uterus weighing exceeding 500 grams: technique and initial report.
|
J Minim Invasive Gynecol
|
2010
|
0.87
|
|
48
|
Phase II study of neoadjuvant chemotherapy with mitomycin-c, vincristine and cisplatin (MVC) in patients with stages IB2-IIB cervical carcinoma.
|
Gynecol Oncol
|
2006
|
0.87
|
|
49
|
Prognostic value of baseline lymphocyte count in cervical carcinoma treated with concurrent chemoradiation.
|
Int J Radiat Oncol Biol Phys
|
2007
|
0.87
|
|
50
|
Dynamic contrast-enhanced magnetic resonance imaging predicts immediate therapeutic response of magnetic resonance-guided high-intensity focused ultrasound ablation of symptomatic uterine fibroids.
|
Invest Radiol
|
2011
|
0.86
|
|
51
|
Gliomatosis peritonei is associated with frequent recurrence, but does not affect overall survival in patients with ovarian immature teratoma.
|
Virchows Arch
|
2012
|
0.86
|
|
52
|
Squamous cell carcinoma with sarcomatoid features of the vulva: a case report and review of literature.
|
Gynecol Oncol
|
2006
|
0.86
|
|
53
|
Preliminary results of neoadjuvant chemotherapy with paclitaxel and cisplatin in patients with advanced epithelial ovarian cancer who are inadequate for optimum primary surgery.
|
J Obstet Gynaecol Res
|
2006
|
0.86
|
|
54
|
The effects of selenium on tumor growth in epithelial ovarian carcinoma.
|
J Gynecol Oncol
|
2012
|
0.86
|
|
55
|
A comparison of uterine papillary serous, clear cell carcinomas, and grade 3 endometrioid corpus cancers using 2009 FIGO staging system.
|
J Gynecol Oncol
|
2013
|
0.86
|
|
56
|
Single-port access (SPA) laparoscopic surgery in gynecology: a surgeon's experience with an initial 200 cases.
|
Eur J Obstet Gynecol Reprod Biol
|
2010
|
0.85
|
|
57
|
High claudin-7 expression is associated with a poor response to platinum-based chemotherapy in epithelial ovarian carcinoma.
|
Eur J Cancer
|
2010
|
0.85
|
|
58
|
Seasonal variation in skin sensitivity to aeroallergens.
|
Allergy Asthma Immunol Res
|
2013
|
0.85
|
|
59
|
Cosmesis and body image after single-port access surgery for gynaecologic disease.
|
Aust N Z J Obstet Gynaecol
|
2012
|
0.85
|
|
60
|
Glucose as a prognostic factor in non-diabetic women with locally advanced cervical cancer (IIB-IVA).
|
Gynecol Oncol
|
2009
|
0.84
|
|
61
|
Overexpression of Galectin-3 and its clinical significance in ovarian carcinoma.
|
Int J Clin Oncol
|
2011
|
0.84
|
|
62
|
Clinical significance of galectin-7 in epithelial ovarian cancer.
|
Anticancer Res
|
2013
|
0.84
|
|
63
|
Clinical significance of pmTOR expression in endometrioid endometrial carcinoma.
|
Eur J Obstet Gynecol Reprod Biol
|
2010
|
0.84
|
|
64
|
Accuracy of frozen section diagnosis of borderline ovarian tumors.
|
Gynecol Oncol
|
2011
|
0.84
|
|
65
|
High expression of mTOR is associated with radiation resistance in cervical cancer.
|
J Gynecol Oncol
|
2010
|
0.84
|
|
66
|
Ovarian metastasis from pulmonary adenocarcinoma.
|
Obstet Gynecol Sci
|
2013
|
0.84
|
|
67
|
Overexpression of annexin A4 is associated with chemoresistance in papillary serous adenocarcinoma of the ovary.
|
Hum Pathol
|
2013
|
0.83
|
|
68
|
High expression of tissue inhibitor of metalloproteinase-2 in serous ovarian carcinomas and the role of this expression in ovarian tumorigenesis.
|
Hum Pathol
|
2006
|
0.83
|
|
69
|
Which is worse: uterine papillary serous carcinomas or carcinosarcomas?
|
J Gynecol Oncol
|
2011
|
0.83
|
|
70
|
Direct interaction between cohesin complex and DNA replication machinery.
|
Biochem Biophys Res Commun
|
2006
|
0.83
|
|
71
|
Expression of CD44 adhesion molecules on human placentae.
|
Eur J Obstet Gynecol Reprod Biol
|
2006
|
0.82
|
|
72
|
The interactions between MicroRNA-200c and BRD7 in endometrial carcinoma.
|
Gynecol Oncol
|
2011
|
0.82
|
|
73
|
Chemo-resistant choriocarcinoma metastatic to colon cured by low-anterior resection.
|
J Gynecol Oncol
|
2011
|
0.82
|
|
74
|
Low dynamin 2 expression is associated with tumor invasion and metastasis in invasive squamous cell carcinoma of cervix.
|
Cancer Biol Ther
|
2010
|
0.82
|
|
75
|
A review of the technique and complications from 2,012 cases of laparoscopically assisted vaginal hysterectomy at a single institution.
|
Aust N Z J Obstet Gynaecol
|
2011
|
0.81
|
|
76
|
Angiomyofibroblastoma of the vulva.
|
Obstet Gynecol Sci
|
2013
|
0.81
|
|
77
|
Safety and efficacy of aprepitant, ramosetron, and dexamethasone for chemotherapy-induced nausea and vomiting in patients with ovarian cancer treated with paclitaxel/carboplatin.
|
Support Care Cancer
|
2013
|
0.81
|
|
78
|
Conization using electrosurgical conization and cold coagulation for international federation of gynecology and obstetrics stage IA1 squamous cell carcinomas of the uterine cervix.
|
Int J Gynecol Cancer
|
2009
|
0.81
|
|
79
|
Prognostic significance of VEGF expression in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy.
|
BMC Cancer
|
2008
|
0.81
|
|
80
|
Sexual function after surgery for early-stage cervical cancer: is there a difference in it according to the extent of surgical radicality?
|
J Sex Med
|
2012
|
0.81
|
|
81
|
Direct inhibition of eIF4E reduced cell growth in endometrial adenocarcinoma.
|
J Cancer Res Clin Oncol
|
2010
|
0.80
|
|
82
|
Uterine endometrial carcinoma: 10 years' experience with long-term follow-up at a single Korean institution.
|
Gynecol Obstet Invest
|
2012
|
0.80
|
|
83
|
Prognostic significance of p-STAT3 in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy.
|
J Obstet Gynaecol Res
|
2010
|
0.80
|
|
84
|
What is the learning curve for single-port access laparoscopic-assisted vaginal hysterectomy?
|
Eur J Obstet Gynecol Reprod Biol
|
2011
|
0.80
|
|
85
|
Increased expression of calpain 6 during the progression of uterine cervical neoplasia: immunohistochemical analysis.
|
Oncol Rep
|
2008
|
0.80
|
|
86
|
Clinical significance of changes in peripheral lymphocyte count after surgery in early cervical cancer.
|
Gynecol Oncol
|
2012
|
0.80
|
|
87
|
Angiotensin II type I receptor and miR-155 in endometrial cancers: synergistic antiproliferative effects of anti-miR-155 and losartan on endometrial cancer cells.
|
Gynecol Oncol
|
2012
|
0.80
|
|
88
|
Factors associated with complications and conversion to laparotomy in women undergoing laparoscopically assisted vaginal hysterectomy.
|
Acta Obstet Gynecol Scand
|
2012
|
0.79
|
|
89
|
Comparison of laparoscopic-assisted radical vaginal hysterectomy and laparoscopic radical hysterectomy in the treatment of cervical cancer.
|
Ann Surg Oncol
|
2012
|
0.79
|
|
90
|
Robotic versus laparoscopic radical hysterectomy in cervical cancer patients: a matched-case comparative study.
|
Int J Gynecol Cancer
|
2014
|
0.79
|
|
91
|
Prognostic factors influencing decisions about surgical treatment of villoglandular adenocarcinoma of the uterine cervix.
|
Int J Gynecol Cancer
|
2014
|
0.79
|
|
92
|
Oncologic and reproductive outcomes of cystectomy compared with oophorectomy as a treatment for borderline ovarian tumours.
|
Hum Reprod
|
2011
|
0.79
|
|
93
|
Uterine fibroids: semiquantitative perfusion MR imaging parameters associated with the intraprocedural and immediate postprocedural treatment efficiencies of MR imaging-guided high-intensity focused ultrasound ablation.
|
Radiology
|
2014
|
0.79
|
|
94
|
Laparoendoscopic single-site surgery with hysterectomy in patients with prior cesarean section: comparison of surgical outcomes with bladder dissection techniques.
|
J Minim Invasive Gynecol
|
2013
|
0.79
|
|
95
|
Topotecan combined with carboplatin in recurrent epithelial ovarian cancer: results of a single-institutional phase II study.
|
Gynecol Oncol
|
2009
|
0.79
|
|
96
|
Clinical significance of HIF-2α immunostaining area in radioresistant cervical cancer.
|
J Gynecol Oncol
|
2011
|
0.79
|
|
97
|
Ploidy and S-phase fraction are correlated with lymphovascular space invasion that is predictive of outcomes in endometrial cancer.
|
Int J Clin Oncol
|
2011
|
0.79
|
|
98
|
A faster nonsurgical solution very large fibroid tumors yielded to a new ablation strategy.
|
Am J Obstet Gynecol
|
2011
|
0.79
|
|
99
|
Does single-port access (SPA) laparoscopy mean reduced pain? A retrospective cohort analysis between SPA and conventional laparoscopy.
|
Eur J Obstet Gynecol Reprod Biol
|
2012
|
0.78
|
|
100
|
Expression of 67-kDa laminin receptor was associated with tumor progression and poor prognosis in epithelial ovarian cancer.
|
Gynecol Oncol
|
2012
|
0.78
|
|
101
|
Single-port access laparoscopic surgery using a novel laparoscopic port (Octo-Port).
|
Taiwan J Obstet Gynecol
|
2011
|
0.78
|
|
102
|
Cross-cultural adaptation of the Korean version of the Boston carpal tunnel questionnaire: its clinical evaluation in patients with carpal tunnel syndrome following local corticosteroid injection.
|
J Korean Med Sci
|
2013
|
0.78
|
|
103
|
Factors influencing the choice of laparoscopy or laparotomy in pregnant women with presumptive benign ovarian tumors.
|
Int J Gynaecol Obstet
|
2010
|
0.78
|
|
104
|
Platinum-based combination chemotherapy vs. weekly cisplatin during adjuvant CCRT in early cervical cancer with pelvic LN metastasis.
|
Anticancer Res
|
2013
|
0.78
|
|
105
|
Germline mutations of BRCA1 in two Korean hereditary breast/ovarian cancer families.
|
Oncol Rep
|
2006
|
0.78
|
|
106
|
Phase II study of ifosfamide and cisplatin for the treatment of recurrent ovarian cancer.
|
Cancer Chemother Pharmacol
|
2013
|
0.78
|
|
107
|
Efficient siRNA delivery into tumor cells by p19-YSA fusion protein.
|
Mol Pharm
|
2013
|
0.78
|
|
108
|
Management and outcome of rectal injury during gynecologic laparoscopic surgery.
|
J Minim Invasive Gynecol
|
2013
|
0.77
|
|
109
|
Fertility-sparing surgery for borderline ovarian tumors: oncologic safety and reproductive outcomes.
|
Int J Gynecol Cancer
|
2011
|
0.77
|
|
110
|
Prognostic significance of DNA ploidy in stage I endometrial cancer.
|
Gynecol Oncol
|
2011
|
0.77
|
|
111
|
RAR-beta expression is associated with early volumetric changes to radiation therapy in cervical cancer.
|
Gynecol Obstet Invest
|
2010
|
0.77
|
|
112
|
Genetic profiling to predict recurrence of early cervical cancer.
|
Gynecol Oncol
|
2013
|
0.77
|
|
113
|
Preoperative multiplication of neutrophil and monocyte counts as a prognostic factor in epithelial ovarian cancer.
|
Cancer Biomark
|
2016
|
0.76
|
|
114
|
Oncologic and reproductive outcomes in patients with advanced-stage borderline ovarian tumors.
|
Eur J Obstet Gynecol Reprod Biol
|
2011
|
0.76
|
|
115
|
MR imaging in endometrial carcinoma as a diagnostic tool for the prediction of myometrial invasion and lymph node metastasis.
|
Cancer Res Treat
|
2007
|
0.76
|
|
116
|
Patterns of recurrence in endometrial cancer patients at risk of lymph node metastasis or recurrence according to extent of lymphadenectomy.
|
Int J Gynecol Cancer
|
2012
|
0.76
|
|
117
|
Long-term recurrence-free survival in a patient with stage IVB uterine carcinosarcoma.
|
J Gynecol Oncol
|
2011
|
0.75
|
|
118
|
Phase II study of combination chemotherapy with etoposide and ifosfamide in patients with heavily pretreated recurrent or persistent epithelial ovarian cancer.
|
J Korean Med Sci
|
2009
|
0.75
|
|
119
|
Endocervical-like versus intestinal-type mucinous borderline ovarian tumors: a large retrospective series focusing on the clinicopathologic characteristics.
|
Gynecol Obstet Invest
|
2013
|
0.75
|
|
120
|
Learning curves for single-site laparoscopic ovarian surgery.
|
J Minim Invasive Gynecol
|
2012
|
0.75
|
|
121
|
Sequence-dependent hematologic side effects of topotecan and cisplatin in persistent or recurrent cervical cancer.
|
Gynecol Oncol
|
2010
|
0.75
|
|
122
|
Comparison of laparoendoscopic single-site hysterectomies: laparoscopic hysterectomy with some vaginal component versus laparoscopically assisted vaginal hysterectomy.
|
J Laparoendosc Adv Surg Tech A
|
2014
|
0.75
|
|
123
|
Pediatric borderline ovarian tumors: a retrospective analysis.
|
J Pediatr Surg
|
2010
|
0.75
|
|
124
|
Phase II study of belotecan, a camptothecin analogue, in combination with carboplatin for the treatment of recurrent ovarian cancer.
|
Cancer
|
2010
|
0.75
|
|
125
|
Prognosis in patients with serous and mucinous stage I borderline ovarian tumors.
|
Int J Gynecol Cancer
|
2012
|
0.75
|
|
126
|
Elevated Preoperative CA125 or CA19-9 in Borderline Ovarian Tumors: Could It Be Suggestive of Advanced Stage or a Poor Prognosis?
|
Gynecol Obstet Invest
|
2017
|
0.75
|
|
127
|
Risk factors for progression to invasive carcinoma in patients with borderline ovarian tumors.
|
Int J Gynecol Cancer
|
2014
|
0.75
|
|
128
|
Myxoid malignant fibrous histiocytoma of the ovary: a case report.
|
Int J Clin Oncol
|
2011
|
0.75
|
|
129
|
Differential expressions of Fas and Fas ligand in human placenta.
|
J Korean Med Sci
|
2002
|
0.75
|
|
130
|
Long-term Outcomes of MRI Stage IIB Cervical Cancer.
|
Int J Gynecol Cancer
|
2016
|
0.75
|
|
131
|
Parametrial Involvement on Magnetic Resonance Imaging Has No Effect on the Survival of Early-Stage Cervical Cancer Patients.
|
Int J Gynecol Cancer
|
2017
|
0.75
|
|
132
|
The effect of high-intensity focused ultrasound in combination with cisplatin using a Xenograft model of cervical cancer.
|
Anticancer Res
|
2012
|
0.75
|
|
133
|
Dynamin 2 expression as a biomarker in grading of cervical intraepithelial neoplasia.
|
Eur J Obstet Gynecol Reprod Biol
|
2012
|
0.75
|
|
134
|
Correlation between location of transposed ovary and function in cervical cancer patients who underwent radical hysterectomy.
|
Int J Gynecol Cancer
|
2015
|
0.75
|
|
135
|
Perioperative Outcomes of Radical Trachelectomy in Early-Stage Cervical Cancer: Vaginal Versus Laparoscopic Approaches.
|
Int J Gynecol Cancer
|
2015
|
0.75
|